Related Experiment Video
Updated: May 1, 2026

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure
Published on: March 20, 2012
Teratogenicity with olanzapine
Sathya Prakash1, Rakesh Kumar Chadda1
1Department of Psychiatry, All India Institute of Medical Sciences, New Delhi, India.
Abstract:
Olanzapine, a 2(nd) generation antipsychotic, is in use in the clinical practice for nearly a decade and a half now. It is classified as a category C drug with very few reports of its toxic effects on the fetus. In general, the risk benefit analysis warrants its use in pregnancy. We report a case of microcephaly and anopthalmos associated with the use of olanzapine in pregnancy. Although a causal role cannot be unequivocally proven, it calls for larger studies to explore this issue.
Related Concept Videos
Teratogenicity
Psychosis: Goals of Pharmacotherapy
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Drug Toxicity: Risk factors
Antipsychotic Drugs: Typical and Atypical Agents

